It is a chemicals and materials private limited company based in Khed, Maharashtra, India, established in 2019.
2019 | Khed, Maharashtra, India | ActiveNovel Molecules Private Limited, a active private limited company, was established on 10 December 2019 in Khed, Maharashtra, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U24297PN2019PTC188316. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Sahil Pradeep Mulaokar (Director), Pradeep Digamber Mulaokar (Additional Director). Past directors included Sandesh Jagannath Shinde. It holds ₹2.98 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. B-45, Midc, Lote, Parshuram,, Khed, Maharashtra, 415722.
U24297PN2019PTC188316
188316
10 December 2019
₹0.50 M
₹0.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Novel Molecules Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sahil Pradeep Mulaokar | Director | 10 Dec 2019 | Current |
| Pradeep Digamber Mulaokar | Additional Director | 14 Aug 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 14 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novel Molecules Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 166.79% increase. The company also saw a substantial improvement in profitability, with a 392.68% increase in profit. The company's net worth Soared by an impressive increase of 200.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Novel Molecules had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,975,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Oct 2021 | Others | ₹1.80 M | Open |
| 07 Sep 2021 | Others | ₹1.18 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novel Molecules, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novel Molecules, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Molecules's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Novel Molecules Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
The activity Novel Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was completed.
A charge with Others amounted to Rs. 1.80 M with Charge ID 100502702 was registered on 05 Oct 2021. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 1.18 M with Charge ID 100484026 was registered on 07 Sep 2021. was completed.
Progress on Pradeep Digamber Mulaokar was appointed as a Additional Director was appointed as a Additional Director on 14 Aug 2021 & has been associated with this company since 4 years 4 months . was documented.
Progress on Sahil Pradeep Mulaokar was appointed as a Director was appointed as a Director on 10 Dec 2019 & has been associated with this company since 6 years 14 days . was documented.
The CIN of Novel Molecules Private Limited is U24297PN2019PTC188316.
Novel Molecules Private Limited is headquartered at Plot No. B-45, Midc, Lote, Parshuram,, Khed, Maharashtra, 415722.
Novel Molecules Private Limited was incorporated on 10 December 2019.
The current directors of Novel Molecules Private Limited are
The primary industry of Novel Molecules Private Limited is Trade.
Novel Molecules Private Limited is unlisted.
The authorized capital of Novel Molecules Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX